Use Nilogen’s fresh patient tumoroid platform for new oncology and immuno-oncology drug candidate screening, evaluation of drug combinations, biomarker discovery, understanding drug mechanism of action and more.
Our website uses cookies to improve your experience. By continuing to browse our website, you accept the use of cookies.AcceptPrivacy policy